Latest News in the pharma Industry

Top Stories

EMA Confirms Positive Benefit-risk Balance of Somatropin-Containing Medicines

EMA Confirms Positive Benefit-risk Balance of Somatropin-Containing Medicines

16 Dec 2011

The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) confirms that the benefit-risk balance of somatropin-containing medicines remains positive.

Read more 
Enlight Teams up with AZ and Novo

Enlight Teams up with AZ and Novo

16 Dec 2011

Enlight Biosciences has formed new partnerships with UK-based AstraZeneca and Denmark-based Novo Nordisk for the development of potentially transformational technologies.

Read more 
Eisai Submits Aricept Application in Japan

Eisai Submits Aricept Application in Japan

15 Dec 2011

Eisai has submitted a marketing and manufacturing authorisation application in Japan to seek approval of a new dry syrup formulation of Aricept.

Read more 
Spanish CRO Kymos Signs Collaboration Agreement with French Ipsen

Spanish CRO Kymos Signs Collaboration Agreement with French Ipsen

15 Dec 2011

Kymos Pharma Services has signed an agreement with the French multinational group Ipsen to take in a team of eight scientists from Ipsen R&D Centre.

Read more 
Patient's Death Raises Questions over Novartis' MS Drug

Patient's Death Raises Questions over Novartis' MS Drug

15 Dec 2011

Since the approval, more than 28,000 patients have received the pill to date and no deaths have occurred until now.

Read more 
Cubist Pharmaceuticals Completes Acquisition of Adolor

Cubist Pharmaceuticals Completes Acquisition of Adolor

14 Dec 2011

Cubist Pharmaceuticals has completed the acquisition of Adolor Corporation for an aggregate upfront cash consideration of approximately $221 million.

Read more 
Simcere & BMS Expand Partnership for Cardiovascular Compound

Simcere & BMS Expand Partnership for Cardiovascular Compound

14 Dec 2011

Simcere will receive exclusive rights to develop and commercialize BMS-795311 in China while Bristol-Myers Squibb will retain exclusive rights in all other markets.

Read more 
Baxter to Acquire Synovis for $260M

Baxter to Acquire Synovis for $260M

14 Dec 2011

The agreement is intended to expand the portfolio of Baxter’s regenerative medicine and biosurgery franchise, which includes a number of devices and biological products for hemostasis, tissue sealing and adherence.

Read more 
Merck Boosts Efforts to Help Eliminate Schistosomiasis in Africa

Merck Boosts Efforts to Help Eliminate Schistosomiasis in Africa

14 Dec 2011

Having originally planned to end the project in 2017, Merck now intends to continue its efforts to fight schistosomiasis indefinitely.

Read more 
ICON Acquires Chinese CRO BeijingWits

ICON Acquires Chinese CRO BeijingWits

13 Dec 2011

The acquisition is a further step in ICON’s on-going expansion in China and the greater Asia-Pacific region.

Read more 
Abbott & Reata Ink Deal for AIMs

Abbott & Reata Ink Deal for AIMs

13 Dec 2011

Abbott and Reata will equally share costs and profits for all new AIMs in all newly licensed indications, except for rheumatoid arthritis and select other autoimmune diseases.

Read more 
Novozymes Expands Partnership with Upperton

Novozymes Expands Partnership with Upperton

12 Dec 2011

Combining Novozymes' IP and expertise around the albumin molecules with Upperton’s rP-conjugate albumin conjugation chemistry knowledge, enables the companies to design and implement the best chemical linking approach for their molecule.

Read more